Last 126.50 GBp
Change Today +2.50 / 2.02%
Volume 0.0
As of 4:00 AM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

instem plc (INS) Snapshot

Open
125.50 GBp
Previous Close
124.00 GBp
Day High
126.50 GBp
Day Low
125.50 GBp
52 Week High
04/1/14 - 197.50 GBp
52 Week Low
11/25/14 - 123.50 GBp
Market Cap
15.2M
Average Volume 10 Days
1.6K
EPS TTM
0.0050 GBp
Shares Outstanding
12.0M
EX-Date
--
P/E TM
253.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for INSTEM PLC (INS)

Related News

No related news articles were found.

instem plc (INS) Related Businessweek News

No Related Businessweek News Found

instem plc (INS) Details

Instem Plc provides IT solutions to the early development healthcare market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include Provantis, a Windows-based system for organizations and universities engaged in non-clinical evaluation studies; ALPHADAS, an eSource, pro-active EDC system for early phase clinical trials; TRP, which provides toxicology solution for pharmaceutical, chemical, and contract research laboratory corporations; DISPENSE, a computer based system for test item control; Logbook, a solution to replace GLP and Non-GLP paper data; Submit, an integrated nonclinical solution suite; and SENDView, an application that simplifies the review of SEND datasets. The company also offers Animal Care Information System, a solution for managing animal facility; Centrus, a solution suite that provides early drug development information from various sources; Safety Intelligence Program, a Web-based database of toxicology and pathology intelligence; SRS, a data integration platform; Metawise, an ontology solution; and OmniViz, a data mining and visual analytics tool. In addition, it offers a range of services comprising project management, installation, validation, data management, training, solution development, remote systems, client support, and specialized solutions. Instem Plc has strategic partnerships with Microsoft; Oracle; CTCLS; Datapipe; SAS; Business Objects; and Asta Development. It serves pharmaceutical, chemical, and contract research organizations, including government and privately funded programs. The company was founded in 1969 and is headquartered in Stone, the United Kingdom.

130 Employees
Last Reported Date: 04/24/14
Founded in 1969

instem plc (INS) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: 146.0K GBP
Chief Financial Officer, Secretary and Direct...
Total Annual Compensation: 94.0K GBP
Compensation as of Fiscal Year 2013.

instem plc (INS) Key Developments

Instem plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2014

Instem plc reported unaudited consolidated earnings results for the six months ended June 30, 2014. For the period, revenue was GBP 5.701 million against GBP 5.484 million a year ago. Loss from operation was GBP 0.495 million against profit from operation of GBP 0.286 million a year ago. Loss before taxation was GBP 0.672 million. Loss for the period attributable to the parent was GBP 0.567 million or 4.7 pence per basic and diluted share against GBP 0.078 million or 0.7 pence per basic and diluted share a year ago. Net cash used in operation was GBP 1.291 million against GBP 0.619 million a year ago. Purchase of intangible assets was GBP 0.311 million against GBP 0.149 million a year ago. Purchase of property, plant and equipment was GBP 0.119 million against GBP 0.105 million a year ago.

Instem Seeks Acquisitions

Instem plc (AIM:INS) will continue to selectively pursue additional bolt-on acquisitions that provide access to adjacent markets and additional growth prospects.

Instem plc to Report First Half, 2014 Results on Sep 24, 2014

Instem plc announced that they will report first half, 2014 results on Sep 24, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INS:LN 126.50 GBp +2.50

INS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for INS.
View Industry Companies
 

Industry Analysis

INS

Industry Average

Valuation INS Industry Range
Price/Earnings 100.0x
Price/Sales 1.2x
Price/Book 3.0x
Price/Cash Flow 15.5x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INSTEM PLC, please visit www.instem-lss.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.